Researchers at the Icahn School of Medicine at Mount Sinai have made an important discovery that could help doctors choose better treatments for patients with recurrent endometrial cancer. Their study ...
Nivolumab is a monoclonal antibody and a PD-1 inhibitor (programmed death receptor inhibitor) which is prescribed for cancer treatment. The therapeutic efficacy of Bacillus calmette-guerin ...
A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...